Soleus Capital Management, L.P.
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 1802630
GREENWICH, CT
Position in INDV
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$38,831,520
New position
Shares Held
1,274,000
first reported quarter
Ownership
1.04%
of shares outstanding
% of Portfolio
1.54%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Soleus Capital Management, L.P. holds $344,937,665 across 8 Drug Manufacturers - Specialty & Generic names. INDV ranks #4 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
187,187 | $110,998,147 | |
| 2 | ALKS |
Alkermes plc.
|
1,970,864 | $69,689,751 | |
| 3 | ANIP |
Ani Pharmaceuticals Inc
|
820,243 | $63,076,686 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
1,274,000 | $38,831,520 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
521,353 | $25,103,146 | |
| 6 | ORGO |
Organogenesis Holdings Inc.
|
10,085,951 | $23,903,703 | |
| 7 | EOLS |
Evolus, Inc.
|
2,245,360 | $9,228,429 | |
| 8 | ETON |
Eton Pharmaceuticals, Inc.
|
166,381 | $4,106,283 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $38,831,520 | 1,274,000 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||